sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-Jul-2016 22:47
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 376-400 out of 1290.

<< < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>

Public Release: 13-Jan-2016
New England Journal of Medicine
Mosquito net safe to use in inguinal hernia repair
Sterilized mosquito nets can replace costly surgical meshes in the repair of inguinal (groin) hernias without further risk to the patients, according to a new Swedish-Ugandan study. This makes mosquito nets a good alternative for close to 200 million people in low-income countries suffering from untreated groin hernias.
Swedish Society of Medicine, Swedish Research Council, Swedish Rotary, Church of Sweden, Capio Research Foundation, and others

Contact: KI Press Office
pressinfo@ki.se
46-085-248-6077
Karolinska Institutet

Public Release: 13-Jan-2016
BioScience
New insights into animal-borne disease outbreaks
To better understand the dynamics of zoonotic diseases, researchers have examined the epidemiology of plague among black-tailed prairie dogs. Their work points to biases that may threaten efforts to better characterize the vectors and transmission of diseases such as Ebola, Middle East respiratory syndrome, and others.
Short Grass Steppe Long Term Ecological Research Grants, Ecology of Infectious Diseases Programs

Contact: James Verdier
jverdier@aibs.org
205-286-8626
American Institute of Biological Sciences

Public Release: 12-Jan-2016
Heliyon
Experts call for more tailored liver cancer care in developing countries
International liver cancer guidelines could be preventing patients from getting life-saving treatments in developing countries, according to a new study published in the journal Heliyon. The authors of the research are calling for treatment guidelines that are more tailored to developing countries, to help save lives.

Contact: Mary Beth O'Leary
m.oleary@elsevier.com
44-020-742-44343
Elsevier

Public Release: 11-Jan-2016
The Lancet
The Institut Pasteur in French Guiana publishes the first complete genome sequence of the Zika virus
Having confirmed the first cases of infection in Suriname then in French Guiana, the Institut Pasteur in French Guiana has sequenced the complete genome of the Zika virus, which is responsible for an unprecedented epidemic currently sweeping through the tropical regions of the Americas. Published in The Lancet medical journal, the analysis of this sequence shows almost complete homology with the strains responsible for the epidemic that occurred in the Pacific in 2013 and 2014.

Contact: Myriam Rebeyrotte
presse@pasteur.fr
Institut Pasteur

Public Release: 11-Jan-2016
Decades-long quest to beat river blindness edges towards vaccine
The world's first vaccine for a disease that causes misery for millions in Africa could be tested within five years.

Contact: Andrew Moffat
andrew.moffat@ed.ac.uk
44-131-650-9836
University of Edinburgh

Public Release: 8-Jan-2016
Scientific Reports
ASU scientists discover how blue and green clays kill bacteria
ASU scientists have discovered the two key ingredients that give some natural clays the power to kill even antibiotic-resistant microbes.
National Science Foundation

Contact: Robert Burnham
robert.burnham@asu.edu
480-458-8207
Arizona State University

Public Release: 8-Jan-2016
Dr. W. Ian Lipkin receives China's top science honor
W. Ian Lipkin, MD, director of the Center for Infection and Immunity at Columbia University's Mailman School of Public Health, received China's top science honor for foreign scientists, the International Science and Technology Cooperation Award at a ceremony on Jan. 8, 2016 presided by China President Xi Jinping. The award recognizes Dr. Lipkin's outstanding contributions to scientific and technological innovation and for promoting scientific advancement in China.

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 8-Jan-2016
The Journal of Pediatrics
Ebola medical team develops guidelines for treating infected children
When the Ebola virus outbreak erupted in West Africa in 2014, children infected with the virus -- particularly those under age 5 -- faced a high risk of death. Researchers involved in their treatment have since developed a set of guidelines aimed at improving how they're treated. They suggest an aggressive approach that includes giving children fluids intravenously; treating other possible infections; feeding them highly fortified food; and increasing the amount of bedside care they receive.

Contact: Judy Martin Finch
martinju@wustl.edu
314-750-4213
Washington University School of Medicine

Public Release: 7-Jan-2016
UC San Diego Skaggs School of Pharmacy and Janssen R&D collaborate to treat Chagas disease
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC (Janssen R&D), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.

Contact: Heather Buschman
hbuschman@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 7-Jan-2016
New research grant awarded to help cut heart disease in South Asia
A new international collaboration has received a £2 million award to fund research into combatting the rising numbers of deaths in rural South Asia caused by cardiovascular disease.
UK Department for International Development, Medical Research Council, Wellcome Trust

Contact: James Barr
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 7-Jan-2016
The Lancet Infectious Diseases
Current malaria treatment fails in Cambodia due to drug-resistant parasites
New findings from NIAID confirm dihydroartemisinin-piperaquine, the first-line treatment for Plasmodium falciparum malaria infection in Cambodia, has failed in certain provinces due to parasite resistance to artemisinin and piperaquine. Additional study findings suggest that artesunate, a form of artemisinin, plus mefloquine, a different long-acting partner drug, should be the first-line ACT in areas where dihydroartemisinin-piperaquine treatment has failed, the study authors note.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 6-Jan-2016
Journal of Medical Entomology
Love hertz
James Cook University researchers have found sex sells when it comes to luring male mosquitoes.

Contact: Alistair Bone
alistair.bone@jcu.edu.au
James Cook University

Public Release: 6-Jan-2016
TTUHSC researcher receives NIH grant for vaccine
Texas Tech University Health Sciences Center researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health. The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials. This phase of the research funding is in collaboration with Darrick Carter, president and CEO of PAI Life Science in Seattle, WA.
National Institutes of Health

Contact: Suzanna Cisneros
suzanna.cisneros@ttuhsc.edu
806-743-7605
Texas Tech University Health Sciences Center

Public Release: 6-Jan-2016
Walter Reed Army Institute of Research begins phase 2 clinical trial of Ebola vaccine
The Walter Reed Army Institute of Research (WRAIR) today began a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers.
Joint Vaccines Acquisition Program at the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense

Contact: Lisa Reilly
lreilly@hivresearch.org
301-500-3633
The U.S. Military HIV Research Program (MHRP)

Public Release: 5-Jan-2016
Academic Medicine
Do no harm: Examining the impact of medical students' short-term international study
International study experiences are a valuable and increasingly expected part of medical students' academic experience, but authors of a new article in Academic Medicine say not all programs leave patients and communities better off. They have recommendations for choosing effective programs and also for shifting the focus to ensure the programs are beneficial for all.

Contact: Peter Bothum
pbothum@udel.edu
302-831-1418
University of Delaware

Public Release: 5-Jan-2016
Journal of Virology
Study shows high frequency of spontaneous mutation in Ebola virus
In a Journal of Virology paper, Texas Biomed Scientist Dr. Anthony Griffiths, explains how he and his team found that Ebola virus has the potential to evolve rapidly but the genetic changes result in viruses that are weakened or not viable, which could be exploited as a therapeutic.

Contact: Lisa Cruz
lcruz@txbiomed.org
210-258-9437
Texas Biomedical Research Institute

Public Release: 4-Jan-2016
Could bug-busting viruses control food poisoning?
Viruses that can seek and destroy food poisoning bugs in the gut are being investigated by researchers at The University of Nottingham, thanks to a prestigious new grant.
Bill and Melinda Gates Foundation

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham

Public Release: 31-Dec-2015
PLOS Neglected Tropical Diseases
Areas of increased poverty associated with higher rates of Ebola transmission
Since October 2014 the Ebola epidemic in West Africa has been diminishing and efforts have shifted from emergency response to prevention and mitigation of future outbreaks.
National Science Foundation, National Institutes of Health

Contact: Mosoka P Fallah
mfallah1969@gmail.com
231-088-834-9115
PLOS

Public Release: 24-Dec-2015
Cell Reports
'Self-sabotage' prevents immune protection against malaria
Australian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the disease. The discovery opens up the possibility of improving new or existing malaria vaccines by boosting key immune cells needed for long-lasting immunity. This could even include vaccines that have previously been ineffective in clinical trials.
National Health and Medical Research Council, Australian Research Council, Sylvia and Charles Viertel Charitable Foundation, Victorian Government Operational Infrastructure Support Program

Contact: Liz Williams
williams@wehi.edu.au
61-428-034-089
Walter and Eliza Hall Institute

Public Release: 23-Dec-2015
SIAM Journal on Applied Mathematics
New SIR-Network Model helps predict dengue fever epidemic in urban areas
An article 'SIR-Network Model And its Application to Dengue Fever,' authored by Lucas M. Stolerman, Daniel Coombs and Stefanella Boatto, published recently in the SIAM Journal on Applied Mathematics introduces a new mathematical model which offers a simplified approach to studying the spread of the infectious virus, Dengue fever, in urban areas, specifically breaking down the epidemic dynamics across a city and its varying neighborhoods and populations.

Contact: Becky Kerner
kerner@siam.org
215-382-9800 x383
Society for Industrial and Applied Mathematics

Public Release: 23-Dec-2015
Lancet Global Health
In China, training doctors reduced STI risk
Results of a randomized, controlled clinical trial in two Chinese provinces show that providing sexually transmitted infection training and education for physicians resulted in significantly reduced infection risk among their patients.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 22-Dec-2015
Nature Communications
NUS researchers uncover potent parasite-killing mechanism of anti-malarial drug
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.

Contact: Goh Yu Chong
yuchong.goh@nus.edu.sg
65-660-11653
National University of Singapore

Public Release: 22-Dec-2015
International Journal of Risk & Safety in Medicine
Towards the rational use of medicines
Rational use of medicines remains to be one of the most challenging problems in health systems worldwide. Kazan Federal University researchers conducted a practical study to assess the impact of introducing evidence-based principles to the practice of medicine procurement in order to manage budget expenditures on medicines of a multidisciplinary health facility for the period of 2011-2014.

Contact: Yevgeniya Litvinova
pressa@kpfu.ru
007-843-273-7345
Kazan Federal University

Public Release: 22-Dec-2015
Lancet Infectious Diseases
Largest study of Ebola survivors finds vision, hearing, joint pain problems
The largest study of survivors of the largest recorded outbreak of Ebola virus disease found they commonly reported complications such as vision, hearing and joint pain problems up to months after they were discharged from an Ebola treatment facility.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 22-Dec-2015
PLOS Medicine
South Africa's child mortality reduction deemed 'a successful failure'
As the 25-year period for the UN Millennium Development Goals concludes on Dec. 31, 2015, to be replaced by the Sustainable Development Goals, a deeper analysis of factors outside defined goals is necessary to learn why some countries failed. This is an argument presented by researchers at Umea University in an article published today in the scientific journal PLOS Medicine.

Contact: Daniel Harju
daniel.harju@umu.se
46-725-522-918
Umea University

Showing releases 376-400 out of 1290.

<< < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>